Literature DB >> 12794106

Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors.

Susan Harless Smith1, Michael P Cancro.   

Abstract

This study examines how B lymphocyte stimulator (BLyS) receptor expression and responsiveness are influenced by B cell receptor (BcR) signaling. Our results show that resting and BcR-stimulated B cells are dependent on BLyS for survival and that B cells remain BLyS responsive during BcR-induced activation. Further, BcR ligation up-regulates expression of the BLySR B cell maturation defect/BLySR3 (Bcmd/BR3), but not other known BLySRs. Finally, the coupling of BcR signaling with Bcmd/BR3 expression is limited to late transitional and mature B cells. Together, these findings establish the coupling of BcR signaling with Bcmd/BR3 expression as a fundamental aspect of follicular B cell selection, survival, and activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794106     DOI: 10.4049/jimmunol.170.12.5820

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2.

Authors:  Iris Castro; Jacqueline A Wright; Bazarragchaa Damdinsuren; Kristen L Hoek; Gianluca Carlesso; Nicholas P Shinners; Rachel M Gerstein; Robert T Woodland; Ranjan Sen; Wasif N Khan
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

Review 2.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

3.  FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation.

Authors:  Jenni E Crowley; Jason E Stadanlick; John C Cambier; Michael P Cancro
Journal:  Blood       Date:  2008-09-12       Impact factor: 22.113

4.  The Autoimmune Risk Variant PTPN22 C1858T Alters B Cell Tolerance at Discrete Checkpoints and Differentially Shapes the Naive Repertoire.

Authors:  Genita Metzler; Xuezhi Dai; Christopher D Thouvenel; Socheath Khim; Tania Habib; Jane H Buckner; David J Rawlings
Journal:  J Immunol       Date:  2017-08-11       Impact factor: 5.422

Review 5.  NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.

Authors:  Li Yu; Ling Li; L Jeffrey Medeiros; Ken H Young
Journal:  Blood Rev       Date:  2016-10-13       Impact factor: 8.250

6.  CD4+ T cells and CD40 participate in selection and homeostasis of peripheral B cells.

Authors:  Marc A Schwartz; Nikita S Kolhatkar; Chris Thouvenel; Socheath Khim; David J Rawlings
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

Review 7.  NF-κB pathways in hematological malignancies.

Authors:  Chiara Gasparini; Claudio Celeghini; Lorenzo Monasta; Giorgio Zauli
Journal:  Cell Mol Life Sci       Date:  2014-01-14       Impact factor: 9.261

8.  Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.

Authors:  Zhong L Ju; Gui Y Shi; Jin X Zuo; Jing W Zhang
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

9.  Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.

Authors:  Julia Jellusova; Ana V Miletic; Matthew H Cato; Wai-Wai Lin; Yinling Hu; Gail A Bishop; Mark J Shlomchik; Robert C Rickert
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

Review 10.  Signalling crosstalk in B cells: managing worth and need.

Authors:  Michael P Cancro
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.